Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 108

1.

Ointments containing Ceratothoa oestroides extract: Evaluation of their healing potential in the treatment of diabetic foot ulcers.

Meimeti E, Tentolouris N, Manes C, Loupa C, Provatopoulou X, Mostratos D, Vitsos A, Roussis V, Tzouvelekis L, Miriagou V, Rallis M.

Wound Repair Regen. 2019 Oct 16. doi: 10.1111/wrr.12771. [Epub ahead of print]

PMID:
31618498
2.

Carbapenem-resistant Acinetobacter baumannii: in pursuit of an effective treatment.

Piperaki ET, Tzouvelekis LS, Miriagou V, Daikos GL.

Clin Microbiol Infect. 2019 Aug;25(8):951-957. doi: 10.1016/j.cmi.2019.03.014. Epub 2019 Mar 23. Review.

PMID:
30914347
3.

A fragment of the alarmin prothymosin α as a novel biomarker in murine models of bacteria-induced sepsis.

Samara P, Miriagou V, Zachariadis M, Mavrofrydi O, Promponas VJ, Dedos SG, Papazafiri P, Kalbacher H, Voelter W, Tsitsilonis O.

Oncotarget. 2017 Jul 25;8(30):48635-48649. doi: 10.18632/oncotarget.18149.

4.

Designed positively charged cyclodextrin hosts with enhanced binding of penicillins as carriers for the delivery of antibiotics: The case of oxacillin.

Agnes M, Thanassoulas A, Stavropoulos P, Nounesis G, Miliotis G, Miriagou V, Athanasiou E, Benkovics G, Malanga M, Yannakopoulou K.

Int J Pharm. 2017 Oct 15;531(2):480-491. doi: 10.1016/j.ijpharm.2017.04.080. Epub 2017 May 1.

PMID:
28473235
5.

attI1-Located Small Open Reading Frames ORF-17 and ORF-11 in a Class 1 Integron Affect Expression of a Gene Cassette Possessing a Canonical Shine-Dalgarno Sequence.

Papagiannitsis CC, Tzouvelekis LS, Tzelepi E, Miriagou V.

Antimicrob Agents Chemother. 2017 Feb 23;61(3). pii: e02070-16. doi: 10.1128/AAC.02070-16. Print 2017 Mar.

6.

Characterization of KPC-encoding plasmids from two endemic settings, Greece and Italy.

Papagiannitsis CC, Di Pilato V, Giani T, Giakkoupi P, Riccobono E, Landini G, Miriagou V, Vatopoulos AC, Rossolini GM.

J Antimicrob Chemother. 2016 Oct;71(10):2824-30. doi: 10.1093/jac/dkw227. Epub 2016 Jun 21.

PMID:
27334661
7.

Comparison of Short Versus Prolonged Infusion of Standard Dose of Meropenem Against Carbapenemase-Producing Klebsiella pneumoniae Isolates in Different Patient Groups: A Pharmacokinetic-Pharmacodynamic Approach.

Vourli S, Tsala M, Kotsakis S, Daikos GL, Tzouvelekis L, Miriagou V, Zerva L, Meletiadis J.

J Pharm Sci. 2016 Apr;105(4):1513-8. doi: 10.1016/j.xphs.2016.02.008.

PMID:
27019965
8.

Draft Genome Sequence of Proteus mirabilis NO-051/03, Representative of a Multidrug-Resistant Clone Spreading in Europe and Expressing the CMY-16 AmpC-Type β-Lactamase.

D'Andrea MM, Giani T, Henrici De Angelis L, Ciacci N, Gniadkowski M, Miriagou V, Torricelli F, Rossolini GM.

Genome Announc. 2016 Feb 11;4(1). pii: e01702-15. doi: 10.1128/genomeA.01702-15.

9.

Pharmacokinetic-pharmacodynamic modelling of meropenem against VIM-producing Klebsiella pneumoniae isolates: clinical implications.

Tsala M, Vourli S, Kotsakis S, Daikos GL, Tzouvelekis L, Zerva L, Miriagou V, Meletiadis J.

J Med Microbiol. 2016 Mar;65(3):211-8. doi: 10.1099/jmm.0.000214. Epub 2015 Dec 23.

PMID:
26697851
10.

Characterization of a Novel lsa(E)- and lnu(B)-Carrying Structure Located in the Chromosome of a Staphylococcus aureus Sequence Type 398 Strain.

Sarrou S, Liakopoulos A, Tsoumani K, Sagri E, Mathiopoulos KD, Tzouvelekis LS, Miriagou V, Petinaki E.

Antimicrob Agents Chemother. 2015 Nov 23;60(2):1164-6. doi: 10.1128/AAC.01178-15. Print 2016 Feb. No abstract available.

11.

Increased Hydrolysis of Oximino-β-Lactams by CMY-107, a Tyr199Cys Mutant Form of CMY-2 Produced by Escherichia coli.

Kotsakis SD, Miriagou V, Vetouli EE, Bozavoutoglou E, Lebessi E, Tzelepi E, Tzouvelekis LS.

Antimicrob Agents Chemother. 2015 Dec;59(12):7894-8. doi: 10.1128/AAC.01793-15. Epub 2015 Oct 5.

12.

Circulation of a multiresistant, conjugative, IncA/C plasmid within the nosocomial Providencia stuartii population in the Athens area.

Giakkoupi P, Tryfinopoulou K, Polemis M, Pappa O, Miriagou V, Vatopoulos A.

Diagn Microbiol Infect Dis. 2015 May;82(1):62-4. doi: 10.1016/j.diagmicrobio.2015.02.009. Epub 2015 Feb 23.

PMID:
25752202
13.

Characterization of a mobilizable IncQ plasmid encoding cephalosporinase CMY-4 in Escherichia coli.

Kotsakis SD, Tzouvelekis LS, Lebessi E, Doudoulakakis A, Bouli T, Tzelepi E, Miriagou V.

Antimicrob Agents Chemother. 2015 May;59(5):2964-6. doi: 10.1128/AAC.05017-14. Epub 2015 Feb 17. No abstract available.

14.

Identification and characterization of genetic structures coding for carbapenemases in Enterobacteria from Central Greece.

Mavroidi A, Liakopoulos A, Sarrou S, Miriagou V, Petinaki E.

Diagn Microbiol Infect Dis. 2015 Jan;81(1):47-9. doi: 10.1016/j.diagmicrobio.2014.09.022. Epub 2014 Oct 2.

PMID:
25445118
15.

Successful control of a neonatal outbreak caused mainly by ST20 multidrug-resistant SHV-5-producing Klebsiella pneumoniae, Greece.

Mavroidi A, Liakopoulos A, Gounaris A, Goudesidou M, Gaitana K, Miriagou V, Petinaki E.

BMC Pediatr. 2014 Apr 17;14:105. doi: 10.1186/1471-2431-14-105.

16.

Emergence and maintenance of multidrug-resistant Escherichia coli of canine origin harbouring a blaCMY-2-IncI1/ST65 plasmid and topoisomerase mutations.

Vingopoulou EI, Siarkou VI, Batzias G, Kaltsogianni F, Sianou E, Tzavaras I, Koutinas A, Saridomichelakis MN, Sofianou D, Tzelepi E, Miriagou V.

J Antimicrob Chemother. 2014 Aug;69(8):2076-80. doi: 10.1093/jac/dku090. Epub 2014 Apr 9.

PMID:
24722836
17.

Identification of CMY-2-type cephalosporinases in clinical isolates of Enterobacteriaceae by MALDI-TOF MS.

Papagiannitsis CC, Kotsakis SD, Tuma Z, Gniadkowski M, Miriagou V, Hrabak J.

Antimicrob Agents Chemother. 2014 May;58(5):2952-7. doi: 10.1128/AAC.02418-13. Epub 2014 Feb 24.

18.

Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems.

Daikos GL, Tsaousi S, Tzouvelekis LS, Anyfantis I, Psichogiou M, Argyropoulou A, Stefanou I, Sypsa V, Miriagou V, Nepka M, Georgiadou S, Markogiannakis A, Goukos D, Skoutelis A.

Antimicrob Agents Chemother. 2014;58(4):2322-8. doi: 10.1128/AAC.02166-13. Epub 2014 Feb 10.

19.

Carbapenemase-producing Pseudomonas aeruginosa from central Greece: molecular epidemiology and genetic analysis of class I integrons.

Liakopoulos A, Mavroidi A, Katsifas EA, Theodosiou A, Karagouni AD, Miriagou V, Petinaki E.

BMC Infect Dis. 2013 Oct 29;13:505. doi: 10.1186/1471-2334-13-505.

20.

Emergence of NDM-producing Klebsiella pneumoniae in Greece.

Giakkoupi P, Tryfinopoulou K, Kontopidou F, Tsonou P, Golegou T, Souki H, Tzouvelekis L, Miriagou V, Vatopoulos A.

Diagn Microbiol Infect Dis. 2013 Dec;77(4):382-4. doi: 10.1016/j.diagmicrobio.2013.09.001. Epub 2013 Oct 14. No abstract available.

PMID:
24135413
21.

OmpK35 and OmpK36 porin variants associated with specific sequence types of Klebsiella pneumoniae.

Papagiannitsis CC, Giakkoupi P, Kotsakis SD, Tzelepi E, Tzouvelekis LS, Vatopoulos AC, Miriagou V.

J Chemother. 2013 Aug;25(4):250-4. doi: 10.1179/1973947813Y.0000000075. No abstract available.

PMID:
23906079
22.

KPC-producing, multidrug-resistant Klebsiella pneumoniae sequence type 258 as a typical opportunistic pathogen.

Tzouvelekis LS, Miriagou V, Kotsakis SD, Spyridopoulou K, Athanasiou E, Karagouni E, Tzelepi E, Daikos GL.

Antimicrob Agents Chemother. 2013 Oct;57(10):5144-6. doi: 10.1128/AAC.01052-13. Epub 2013 Jul 15.

23.

Laboratory evaluation of Brilliance™ CRE Agar for screening carbapenem-resistant Enterobacteriaceae: Performance on a collection of characterised clinical isolates from Greece.

Kotsakis SD, Petinaki E, Scopes E, Siatravani E, Miriagou V, Tzelepi E.

J Glob Antimicrob Resist. 2013 Jun;1(2):85-90. doi: 10.1016/j.jgar.2013.03.004. Epub 2013 Apr 16.

PMID:
27873583
24.

Characterization of pKP1780, a novel IncR plasmid from the emerging Klebsiella pneumoniae ST147, encoding the VIM-1 metallo-β-lactamase.

Papagiannitsis CC, Miriagou V, Giakkoupi P, Tzouvelekis LS, Vatopoulos AC.

J Antimicrob Chemother. 2013 Oct;68(10):2259-62. doi: 10.1093/jac/dkt196. Epub 2013 May 27.

PMID:
23711894
25.

Characterization of pKP1433, a novel KPC-2-encoding plasmid from Klebsiella pneumoniae sequence type 340.

Papagiannitsis CC, Miriagou V, Giakkoupi P, Tzouvelekis LS, Vatopoulos AC.

Antimicrob Agents Chemother. 2013 Jul;57(7):3427-9. doi: 10.1128/AAC.00054-13. Epub 2013 Apr 29.

26.

Combined disc methods for the detection of KPC- and/or VIM-positive Klebsiella pneumoniae: improving reliability for the double carbapenemase producers.

Miriagou V, Tzelepi E, Kotsakis SD, Daikos GL, Bou Casals J, Tzouvelekis LS.

Clin Microbiol Infect. 2013 Sep;19(9):E412-5. doi: 10.1111/1469-0691.12238. Epub 2013 Apr 30.

27.

Ciprofloxacin-resistant Escherichia coli in Central Greece: mechanisms of resistance and molecular identification.

Mavroidi A, Miriagou V, Liakopoulos A, Tzelepi Ε, Stefos A, Dalekos GN, Petinaki E.

BMC Infect Dis. 2012 Dec 23;12:371. doi: 10.1186/1471-2334-12-371.

28.

Interactions of oximino-substituted boronic acids and β-lactams with the CMY-2-derived extended-spectrum cephalosporinases CMY-30 and CMY-42.

Kotsakis SD, Caselli E, Tzouvelekis LS, Petinaki E, Prati F, Miriagou V.

Antimicrob Agents Chemother. 2013 Feb;57(2):968-76. doi: 10.1128/AAC.01620-12. Epub 2012 Dec 10.

29.

Characterisation of CTX-M-117, a Pro174Gln variant of CTX-M-15 extended-spectrum β-lactamase, from a bovine Escherichia coli isolate.

Hächler H, Kotsakis SD, Tzouvelekis LS, Geser N, Lehner A, Miriagou V, Stephan R.

Int J Antimicrob Agents. 2013 Jan;41(1):94-5. doi: 10.1016/j.ijantimicag.2012.09.011. Epub 2012 Nov 3. No abstract available.

PMID:
23127481
30.

Emergence of resistance to fosfomycin used as adjunct therapy in KPC Klebsiella pneumoniae bacteraemia: report of three cases.

Karageorgopoulos DE, Miriagou V, Tzouvelekis LS, Spyridopoulou K, Daikos GL.

J Antimicrob Chemother. 2012 Nov;67(11):2777-9. doi: 10.1093/jac/dks270. Epub 2012 Jul 10. No abstract available.

PMID:
22782489
31.

Characterization of a transmissible plasmid encoding VEB-1 and VIM-1 in Proteus mirabilis.

Papagiannitsis CC, Miriagou V, Kotsakis SD, Tzelepi E, Vatopoulos AC, Petinaki E, Tzouvelekis LS.

Antimicrob Agents Chemother. 2012 Jul;56(7):4024-5. doi: 10.1128/AAC.00470-12. Epub 2012 Apr 30. No abstract available.

32.

Identification and screening of carbapenemase-producing Enterobacteriaceae.

Nordmann P, Gniadkowski M, Giske CG, Poirel L, Woodford N, Miriagou V; European Network on Carbapenemases.

Clin Microbiol Infect. 2012 May;18(5):432-8. doi: 10.1111/j.1469-0691.2012.03815.x. Review.

33.

Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe.

Cantón R, Akóva M, Carmeli Y, Giske CG, Glupczynski Y, Gniadkowski M, Livermore DM, Miriagou V, Naas T, Rossolini GM, Samuelsen Ø, Seifert H, Woodford N, Nordmann P; European Network on Carbapenemases.

Clin Microbiol Infect. 2012 May;18(5):413-31. doi: 10.1111/j.1469-0691.2012.03821.x. Review.

34.

Identification of OXA-23-producing Acinetobacter baumannii in Greece, 2010 to 2011.

Liakopoulos A, Miriagou V, Katsifas EA, Karagouni AD, Daikos GL, Tzouvelekis LS, Petinaki E.

Euro Surveill. 2012 Mar 15;17(11). pii: 20117.

35.

Emergence of Escherichia coli sequence type 410 (ST410) with KPC-2 β-lactamase.

Mavroidi A, Miriagou V, Malli E, Stefos A, Dalekos GN, Tzouvelekis LS, Petinaki E.

Int J Antimicrob Agents. 2012 Mar;39(3):247-50. doi: 10.1016/j.ijantimicag.2011.11.003. Epub 2012 Jan 9.

PMID:
22226650
36.

Detection of Citrobacter koseri carrying beta-lactamase KPC-2 in a hospitalised patient, Greece, July 2011.

Mavroidi A, Neonakis I, Liakopoulos A, Papaioannou A, Ntala M, Tryposkiadis F, Miriagou V, Petinaki E.

Euro Surveill. 2011 Oct 13;16(41). pii: 19990. Erratum in: Euro Surveill. 2011;16(44). pii: 20006.

37.

Effects of the Val211Gly substitution on molecular dynamics of the CMY-2 cephalosporinase: implications on hydrolysis of expanded-spectrum cephalosporins.

Kotsakis SD, Tzouvelekis LS, Petinaki E, Tzelepi E, Miriagou V.

Proteins. 2011 Nov;79(11):3180-92. doi: 10.1002/prot.23150. Epub 2011 Aug 30.

PMID:
21989938
38.

Does it ever make sense to treat a bacterial infection with a drug against which the responsible pathogen possesses a resistance mechanism?

Tassios PT, Miriagou V.

Clin Microbiol Infect. 2011 Aug;17(8):1126-7. doi: 10.1111/j.1469-0691.2011.03579.x. Epub 2011 Jun 20. No abstract available.

39.

Multilocus sequence typing of IncN plasmids.

García-Fernández A, Villa L, Moodley A, Hasman H, Miriagou V, Guardabassi L, Carattoli A.

J Antimicrob Chemother. 2011 Sep;66(9):1987-91. doi: 10.1093/jac/dkr225. Epub 2011 Jun 8.

PMID:
21653604
40.

An update of the evolving epidemic of blaKPC-2-carrying Klebsiella pneumoniae in Greece (2009-10).

Giakkoupi P, Papagiannitsis CC, Miriagou V, Pappa O, Polemis M, Tryfinopoulou K, Tzouvelekis LS, Vatopoulos AC.

J Antimicrob Chemother. 2011 Jul;66(7):1510-3. doi: 10.1093/jac/dkr166. Epub 2011 May 4.

PMID:
21543359
41.

Characterization of metallo-beta-lactamase VIM-27, an A57S mutant of VIM-1 associated with Klebsiella pneumoniae ST147.

Papagiannitsis CC, Kotsakis SD, Petinaki E, Vatopoulos AC, Tzelepi E, Miriagou V, Tzouvelekis LS.

Antimicrob Agents Chemother. 2011 Jul;55(7):3570-2. doi: 10.1128/AAC.00238-11. Epub 2011 Apr 25.

42.

Evolution and spread of a multidrug-resistant Proteus mirabilis clone with chromosomal AmpC-type cephalosporinases in Europe.

D'Andrea MM, Literacka E, Zioga A, Giani T, Baraniak A, Fiett J, Sadowy E, Tassios PT, Rossolini GM, Gniadkowski M, Miriagou V.

Antimicrob Agents Chemother. 2011 Jun;55(6):2735-42. doi: 10.1128/AAC.01736-10. Epub 2011 Mar 14.

43.

CMY-42, a novel plasmid-mediated CMY-2 variant AmpC beta-lactamase.

Hentschke M, Kotsakis SD, Wolters M, Heisig P, Miriagou V, Aepfelbacher M.

Microb Drug Resist. 2011 Jun;17(2):165-9. doi: 10.1089/mdr.2010.0137. Epub 2011 Mar 9.

PMID:
21388298
44.

Analysis of emergence of quinolone-resistant gonococci in Greece by combined use of Neisseria gonorrhoeae multiantigen sequence typing and multilocus sequence typing.

Mavroidi A, Tzelepi E, Siatravani E, Godoy D, Miriagou V, Spratt BG.

J Clin Microbiol. 2011 Apr;49(4):1196-201. doi: 10.1128/JCM.02233-10. Epub 2011 Jan 19.

45.

Sequence of pR3521, an IncB plasmid from Escherichia coli encoding ACC-4, SCO-1, and TEM-1 beta-lactamases.

Papagiannitsis CC, Tzouvelekis LS, Kotsakis SD, Tzelepi E, Miriagou V.

Antimicrob Agents Chemother. 2011 Jan;55(1):376-81. doi: 10.1128/AAC.00875-10. Epub 2010 Oct 18.

46.

Emergence of Klebsiella pneumoniae of a novel sequence type (ST383) producing VIM-4, KPC-2 and CMY-4 β-lactamases.

Papagiannitsis CC, Giakkoupi P, Vatopoulos AC, Tryfinopoulou K, Miriagou V, Tzouvelekis LS.

Int J Antimicrob Agents. 2010 Dec;36(6):573-4. doi: 10.1016/j.ijantimicag.2010.07.018. Epub 2010 Sep 21. No abstract available.

PMID:
20863669
47.

Detection of metallo-β-lactamase genes in clinical specimens by a commercial multiplex PCR system.

Avlami A, Bekris S, Ganteris G, Kraniotaki E, Malamou-Lada E, Orfanidou M, Paniara O, Pantazatou A, Papagiannitsis CC, Platsouka E, Stefanou I, Tzelepi E, Vagiakou H, Miriagou V.

J Microbiol Methods. 2010 Nov;83(2):185-7. doi: 10.1016/j.mimet.2010.08.014. Epub 2010 Aug 31.

PMID:
20807554
48.

Comparative biochemical and computational study of the role of naturally occurring mutations at Ambler positions 104 and 170 in GES β-lactamases.

Kotsakis SD, Miriagou V, Tzelepi E, Tzouvelekis LS.

Antimicrob Agents Chemother. 2010 Nov;54(11):4864-71. doi: 10.1128/AAC.00771-10. Epub 2010 Aug 9.

49.

Sequence of pNL194, a 79.3-kilobase IncN plasmid carrying the blaVIM-1 metallo-beta-lactamase gene in Klebsiella pneumoniae.

Miriagou V, Papagiannitsis CC, Kotsakis SD, Loli A, Tzelepi E, Legakis NJ, Tzouvelekis LS.

Antimicrob Agents Chemother. 2010 Oct;54(10):4497-502. doi: 10.1128/AAC.00665-10. Epub 2010 Jul 26.

50.

An ertapenem-resistant extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae clone carries a novel OmpK36 porin variant.

García-Fernández A, Miriagou V, Papagiannitsis CC, Giordano A, Venditti M, Mancini C, Carattoli A.

Antimicrob Agents Chemother. 2010 Oct;54(10):4178-84. doi: 10.1128/AAC.01301-09. Epub 2010 Jul 26.

Supplemental Content

Loading ...
Support Center